E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
Authors
Keywords
-
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1877, Issue 3, Pages 188736
Publisher
Elsevier BV
Online
2022-05-17
DOI
10.1016/j.bbcan.2022.188736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
- (2022) Hae-Seul Choi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma
- (2022) Lesley Jia Wei Pua et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Dissection of the MKK3 Functions in Human Cancer: A Double-Edged Sword?
- (2022) Valentina Piastra et al. Cancers
- Clinical Significance and Regulation of ERK5 Expression and Function in Cancer
- (2022) Matilde Monti et al. Cancers
- Beyond K48 and K63: non-canonical protein ubiquitination
- (2021) Michal Tracz et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Emerging functions of branched ubiquitin chains
- (2021) Michael E. French et al. Cell Discovery
- c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1
- (2021) Xiaodong Tian et al. CANCER GENE THERAPY
- MAPK signaling regulates c‐MYC for melanoma cell adaptation to asparagine restriction
- (2021) Gaurav Pathria et al. EMBO REPORTS
- Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
- (2021) Hironori Takagi et al. LUNG CANCER
- PROTACs in Treatment of Cancer: A review
- (2021) Poonam Arora et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
- (2021) Ivana Yen et al. NATURE
- MDM2 induces EMT via the B‑Raf signaling pathway through 14‑3‑3
- (2021) Mengting Ou et al. ONCOLOGY REPORTS
- MEKK1 Regulates Chemokine Expression in Mammary Fibroblasts: Implications for the Breast Tumor Microenvironment
- (2021) Saverio Gentile et al. Frontiers in Oncology
- Inhibitory feedback control of NF-κB signalling in health and disease
- (2021) Jack A. Prescott et al. BIOCHEMICAL JOURNAL
- Research progress of MEK1/2 inhibitors and degraders in the treatment of cancer
- (2021) Chao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex‐dependent regulation of glycolysis
- (2021) Matthew E. R. Maitland et al. FASEB JOURNAL
- The MEK5/ERK5 Pathway in Health and Disease
- (2021) Rupesh Paudel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect
- (2021) So-Hee Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emerging strategies to target RAS signaling in human cancer therapy
- (2021) Kun Chen et al. Journal of Hematology & Oncology
- Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
- (2021) Nyree Crawford et al. MOLECULAR CANCER THERAPEUTICS
- K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle
- (2021) Yuanyuan Yu et al. Nature Chemical Biology
- Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
- (2021) Alejandro Garcia-Alvarez et al. OncoTargets and Therapy
- Targeting Protein Kinases Degradation by PROTACs
- (2021) Fei Yu et al. Frontiers in Chemistry
- Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
- (2021) Adrián Sánchez-Fdez et al. npj Precision Oncology
- The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer
- (2021) James F H Pittaway et al. ENDOCRINE-RELATED CANCER
- Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells
- (2021) Xin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
- (2021) Diana Schaufler et al. npj Precision Oncology
- TNF-α-induced E3 ligase, TRIM15 inhibits TNF-α-regulated NF-κB pathway by promoting turnover of K63 linked ubiquitination of TAK1
- (2021) Milton Roy et al. CELLULAR SIGNALLING
- The MEK5-ERK5 kinase axis controls lipid metabolism in small cell lung cancer
- (2020) Sandra Cristea et al. CANCER RESEARCH
- USP15 potentiates NF‐κB activation by differentially stabilizing TAB2 and TAB3
- (2020) Qiaoqiao Zhou et al. FEBS Journal
- Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
- (2020) Shannon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
- (2020) Qinghua Wu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- OTUD1 Negatively Regulates Type I IFN Induction by Disrupting Noncanonical Ubiquitination of IRF3
- (2020) Zeming Zhang et al. JOURNAL OF IMMUNOLOGY
- Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
- (2020) Louis Buscail et al. Nature Reviews Gastroenterology & Hepatology
- Targeted Avenues for Cancer Treatment: The MEK5–ERK5 Signaling Pathway
- (2020) Diane M. Pereira et al. TRENDS IN MOLECULAR MEDICINE
- The ubiquitin ligase HERC1 regulates cell migration via RAF-dependent regulation of MKK3/p38 signaling
- (2020) Leonardo Pedrazza et al. Scientific Reports
- Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner
- (2020) Weiwei Jiang et al. Protein & Cell
- Current Advances in the Treatment of BRAF-Mutant Melanoma
- (2020) Hima Patel et al. Cancers
- Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases—Current State of the Art
- (2020) Karina Smorodinsky-Atias et al. Cells
- Overcoming Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutated Tumours
- (2020) Emily L. Paton et al. Journal of Oncology
- TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
- (2020) Dan Liu et al. Cell Metabolism
- TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
- (2020) Jumpei Teramachi et al. HAEMATOLOGICA
- SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation
- (2020) Tatiana Erazo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The p38 Pathway: From Biology to Cancer Therapy
- (2020) Adrián Martínez-Limón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Understanding MAPK Signaling Pathways in Apoptosis
- (2020) Jicheng Yue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
- (2020) Sajid Khan et al. ONCOGENE
- MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration
- (2020) Fei Zhang et al. PLoS One
- RAS, wanted dead or alive: Advances in targeting RAS mutant cancers
- (2020) Clint A. Stalnecker et al. Science Signaling
- Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases
- (2020) Marwah Karim et al. mBio
- The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer
- (2020) Manel B. Hammouda et al. Cells
- Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer
- (2020) Glenn J. Hanna et al. CANCER
- Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers
- (2020) Hong-Beom Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Specificity in Ubiquitination Triggered by Virus Infection
- (2020) Haidong Gu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- Opposing Oncogenic Functions of p38 Mitogen-activated Protein Kinase Alpha and Beta in Human Pancreatic Cancer Cells
- (2020) XIAODONG TIAN et al. ANTICANCER RESEARCH
- TRIM28 Regulates Dlk1 Expression in Adipogenesis
- (2020) Hsin-Pin Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Arabidopsis E3 ligase KEG associates with and ubiquitinates MKK4 and MKK5 to regulate plant immunity
- (2020) Chenyang Gao et al. Journal of Integrative Plant Biology
- Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells
- (2020) Chien-Hung Yeh et al. Molecular Cancer
- Functions of p38 MAP Kinases in the Central Nervous System
- (2020) Prita R. Asih et al. Frontiers in Molecular Neuroscience
- JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
- (2020) Clara Alice Musi et al. Cells
- Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders
- (2020) Jianping Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Visualizing ubiquitination in mammalian cells
- (2019) Sjoerd JL van Wijk et al. EMBO REPORTS
- Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
- (2019) Blake E. Smith et al. Nature Communications
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo
- (2019) Liang Zhou et al. Journal of Hematology & Oncology
- Impact of ERK5 on the Hallmarks of Cancer
- (2019) Barbara Stecca et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of c-Raf Stability through the CTLH Complex
- (2019) Christina McTavish et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MAPK/ERK Signaling in Regulation of Renal Differentiation
- (2019) Kurtzeborn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p38γ is essential for cell cycle progression and liver tumorigenesis
- (2019) Antonia Tomás-Loba et al. NATURE
- K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling
- (2019) Qing Yin et al. Nature Communications
- MLK 3 silence induces cervical cancer cell apoptosis via the Notch‐1/autophagy network
- (2019) Liya Ma et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
- (2019) Amir Noeparast et al. ONCOGENE
- Branching Out: Improved Signaling by Heterotypic Ubiquitin Chains
- (2019) Diane L. Haakonsen et al. TRENDS IN CELL BIOLOGY
- Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma
- (2019) Ying Zhang et al. Scientific Reports
- BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale
- (2019) Jillian Wilhelmina Paulina Bracht et al. Cancers
- Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
- (2019) Nathan J. Schauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader
- (2019) Jieli Wei et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multifaceted roles of TAK1 signaling in cancer
- (2019) Himadri Mukhopadhyay et al. ONCOGENE
- Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency
- (2019) Jason Buehler et al. PLoS Pathogens
- A Comparative Analysis of Individual RAS Mutations in Cancer Biology
- (2019) Carmen Muñoz-Maldonado et al. Frontiers in Oncology
- The role of JNK in prostate cancer progression and therapeutic strategies
- (2019) Ruiyuan Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, Synthesis, and Biological Evaluation of MEK PROTACs
- (2019) Stefan Vollmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- c-Raf in KRas Mutant Cancers: A Moving Target
- (2018) Frank McCormick CANCER CELL
- Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells
- (2018) Begoña Cánovas et al. CANCER CELL
- M1-linked ubiquitination by LUBEL is required for inflammatory responses to oral infection in Drosophila
- (2018) Anna L. Aalto et al. CELL DEATH AND DIFFERENTIATION
- Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
- (2018) Azad Saei et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
- (2018) Yan-Xiao Ji et al. NATURE MEDICINE
- MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function
- (2018) Jinqiu Lu et al. ONCOGENE
- K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains
- (2018) Fumiaki Ohtake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth
- (2018) Wenjuan Li et al. Cell Death & Disease
- TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
- (2018) Oihana Iriondo et al. Nature Communications
- Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
- (2018) Yijun Gao et al. Cancer Discovery
- Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates p38 Signaling to Synergistically Suppress Glioblastoma Progression
- (2018) Kunpeng Liu et al. Cell Reports
- BRAF inhibitors in metastatic non-small cell lung cancer
- (2018) Geòrgia Anguera et al. Journal of Thoracic Disease
- MEK5 promotes lung adenocarcinoma
- (2018) Adrián Sánchez-Fdez et al. EUROPEAN RESPIRATORY JOURNAL
- Hippo kinase NDR2 inhibits IL-17 signaling by promoting Smurf1-mediated MEKK2 ubiquitination and degradation
- (2018) Xianwei Ma et al. MOLECULAR IMMUNOLOGY
- The ERK and JNK pathways in the regulation of metabolic reprogramming
- (2018) Salvatore Papa et al. ONCOGENE
- XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells
- (2017) You-Jin Lee et al. ENVIRONMENTAL TOXICOLOGY
- 1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma
- (2017) Yi-Min Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Post-Translational Modifications of the TAK1-TAB Complex
- (2017) Yusuke Hirata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment
- (2017) M Wada et al. ONCOGENE
- Role of JNK signaling in oral cancer: A mini review
- (2017) Ioannis Gkouveris et al. TUMOR BIOLOGY
- The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function
- (2017) Lixin Wan et al. Cancer Discovery
- Relaxation oscillations and hierarchy of feedbacks in MAPK signaling
- (2017) Marek Kochańczyk et al. Scientific Reports
- TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1
- (2017) Yusuke Hirata et al. Cell Reports
- Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
- (2017) Mark Merchant et al. PLoS One
- p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2
- (2016) Christopher M. Schonhoff et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins
- (2016) Mi Hee Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- BRAFV600E mutation in hairy cell leukemia: from bench to bedside
- (2016) Brunangelo Falini et al. BLOOD
- MEK5 overexpression is associated with the occurrence and development of colorectal cancer
- (2016) Dechang Diao et al. BMC CANCER
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
- (2016) Scott A. Foster et al. CANCER CELL
- Regulation of pluripotency and differentiation by deubiquitinating enzymes
- (2016) B Suresh et al. CELL DEATH AND DIFFERENTIATION
- The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target
- (2016) André E.S. Simões et al. DRUG DISCOVERY TODAY
- JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships
- (2016) András Zeke et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis
- (2016) Fang Liu et al. ONCOLOGY REPORTS
- The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
- (2016) Lei Li et al. Oncology Letters
- The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
- (2016) Yan-Xiao Ji et al. Nature Communications
- RNF166 Determines Recruitment of Adaptor Proteins during Antibacterial Autophagy
- (2016) Robert J. Heath et al. Cell Reports
- Lys29-linkage of ASK1 by Skp1−Cullin 1−Fbxo21 ubiquitin ligase complex is required for antiviral innate response
- (2016) Zhou Yu et al. eLife
- MLK3 Signaling in Cancer Invasion
- (2016) Chotirat Rattanasinchai et al. Cancers
- Ras activation revisited: role of GEF and GAP systems
- (2015) Anne Hennig et al. BIOLOGICAL CHEMISTRY
- TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity
- (2015) Jiali Zhong et al. MEDICAL ONCOLOGY
- K63 polyubiquitination is a new modulator of the oxidative stress response
- (2015) Gustavo M Silva et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Neddylation controls basal MKK7 kinase activity in breast cancer cells
- (2015) T Zhu et al. ONCOGENE
- K63 polyubiquitination is a new modulator of the oxidative stress response
- (2015) Gustavo M Silva et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- RNF168 Promotes Noncanonical K27 Ubiquitination to Signal DNA Damage
- (2015) Marco Gatti et al. Cell Reports
- HTLV-1 Tax Stimulates Ubiquitin E3 Ligase, Ring Finger Protein 8, to Assemble Lysine 63-Linked Polyubiquitin Chains for TAK1 and IKK Activation
- (2015) Yik-Khuan Ho et al. PLoS Pathogens
- Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization
- (2015) Mingjia Tan et al. NEOPLASIA
- Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet
- (2015) Grant A. McArthur Frontiers in Oncology
- MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells
- (2014) Ahmed A. Mirza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells
- (2014) Hongjun Peng et al. BMC MICROBIOLOGY
- MKK6 is Upregulated in Human Esophageal, Stomach, and Colon Cancers
- (2014) Arif Ali Parray et al. CANCER INVESTIGATION
- ERKs in Cancer: Friends or Foes?
- (2014) Xavier Deschênes-Simard et al. CANCER RESEARCH
- Enhanced Protein Degradation by Branched Ubiquitin Chains
- (2014) Hermann-Josef Meyer et al. CELL
- Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1
- (2014) A.-N. Takeda et al. EMBO JOURNAL
- The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 Kinase by Modifying the Adaptor STING
- (2014) Qiang Wang et al. IMMUNITY
- Identification of a Peptide Inhibitor of the RPM-1·FSN-1 Ubiquitin Ligase Complex
- (2014) Jaiprakash Sharma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Roles of p38 Mitogen-Activated Protein Kinase in Macrophage-Mediated Inflammatory Responses
- (2014) Yanyan Yang et al. MEDIATORS OF INFLAMMATION
- HUWE1 Is a Molecular Link Controlling RAF-1 Activity Supported by the Shoc2 Scaffold
- (2014) E. R. Jang et al. MOLECULAR AND CELLULAR BIOLOGY
- The E3 Ligase CHIP Mediates Ubiquitination and Degradation of Mixed-Lineage Kinase 3
- (2014) Natalya A. Blessing et al. MOLECULAR AND CELLULAR BIOLOGY
- K33-Linked Polyubiquitination of Coronin 7 by Cul3-KLHL20 Ubiquitin E3 Ligase Regulates Protein Trafficking
- (2014) Wei-Chien Yuan et al. MOLECULAR CELL
- Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer
- (2014) E Lemieux et al. ONCOGENE
- Roquin-2 Promotes Ubiquitin-Mediated Degradation of ASK1 to Regulate Stress Responses
- (2014) T. Maruyama et al. Science Signaling
- Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
- (2014) Yingxi Xu et al. TRENDS IN BIOCHEMICAL SCIENCES
- The E3 Ligase CHIP: Insights into Its Structure and Regulation
- (2014) Indranil Paul et al. Biomed Research International
- JNK signalling in cancer: in need of new, smarter therapeutic targets
- (2013) Concetta Bubici et al. BRITISH JOURNAL OF PHARMACOLOGY
- When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling
- (2013) Lan K Nguyen et al. Cell Communication and Signaling
- Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
- (2013) A. L. Pritchard et al. CLINICAL CANCER RESEARCH
- USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complex
- (2013) Xikui Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Amplification and over-expression ofMAP3K3gene in human breast cancer promotes formation and survival of breast cancer cells
- (2013) Yihui Fan et al. JOURNAL OF PATHOLOGY
- Oncogenic H-Ras Reprograms Madin-Darby Canine Kidney (MDCK) Cell-derived Exosomal Proteins Following Epithelial-Mesenchymal Transition
- (2013) Bow J. Tauro et al. MOLECULAR & CELLULAR PROTEOMICS
- Overexpression of MEKK2 is associated with colorectal carcinogenesis
- (2013) LI JIANG et al. Oncology Letters
- BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
- (2012) Rachel N. Grisham et al. CANCER
- Inactivation of the Deubiquitinase CYLD in Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, and Cancer
- (2012) Kostas Nikolaou et al. CANCER CELL
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- ERK5: Structure, regulation and function
- (2012) Gopika N. Nithianandarajah-Jones et al. CELLULAR SIGNALLING
- Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)
- (2012) Seung-Woo Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Direct and Indirect Control of Mitogen-activated Protein Kinase Pathway-associated Components, BRAP/IMP E3 Ubiquitin Ligase and CRAF/RAF1 Kinase, by the Deubiquitylating Enzyme USP15
- (2012) Sebastian D. Hayes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- Role of JNK in Mammary Gland Development and Breast Cancer
- (2011) C. Cellurale et al. CANCER RESEARCH
- USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation
- (2011) Y-H Fan et al. CELL DEATH AND DIFFERENTIATION
- Stability of F-box Protein Atrogin-1 is Regulated by p38 Mitogen-activated Protein Kinase Pathway in Cardiac H9c2 Cells
- (2011) Jun-Jie Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
- (2011) Neesar Ahmed et al. NATURE IMMUNOLOGY
- Evolutionary History of the Vertebrate Mitogen Activated Protein Kinases Family
- (2011) Meng Li et al. PLoS One
- Tripartite motif 8 (TRIM8) modulates TNF - and IL-1 -triggered NF- B activation by targeting TAK1 for K63-linked polyubiquitination
- (2011) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Axon regeneration requires coordinate activation of p38 and JNK MAPK pathways
- (2011) P. Nix et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Targets of Raf in tumorigenesis
- (2010) T. S. Niault et al. CARCINOGENESIS
- K33-Linked Polyubiquitination of T Cell Receptor-ζ Regulates Proteolysis-Independent T Cell Signaling
- (2010) Haining Huang et al. IMMUNITY
- Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth
- (2010) Yaxiong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development
- (2010) W-L Yang et al. ONCOGENE
- ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis
- (2009) Takayuki Iriyama et al. EMBO JOURNAL
- The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
- (2009) Hae-Young Yong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lysine 63-linked Polyubiquitination of TAK1 at Lysine 158 Is Required for Tumor Necrosis Factor α- and Interleukin-1β-induced IKK/NF-κB and JNK/AP-1 Activation
- (2009) Yihui Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MKK4/SEK1 Is Negatively Regulated through a Feedback Loop Involving the E3 Ubiquitin Ligase Itch
- (2009) Young-Ho Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells
- (2009) Fuqin Su et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Ubiquitin-like Sequence in ASK1 Plays Critical Roles in the Recognition and Stabilization by USP9X and Oxidative Stress-Induced Cell Death
- (2009) Hiroaki Nagai et al. MOLECULAR CELL
- XIAP regulates bi-phasic NF-κB induction involving physical interaction and ubiquitination of MEKK2
- (2008) Gabriele Winsauer et al. CELLULAR SIGNALLING
- Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
- (2008) Lijian Hui et al. JOURNAL OF CLINICAL INVESTIGATION
- X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility
- (2008) Taner Dogan et al. NATURE CELL BIOLOGY
- JNK signaling in apoptosis
- (2008) D N Dhanasekaran et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now